# Treatment Study of Bipolar Depression

> **NCT00947791** · PHASE4 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 1 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** ketamine
- **DRUG:** midazolam

## Key facts

- **NCT ID:** NCT00947791
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Change in available resources for study procedures
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947791, "Treatment Study of Bipolar Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00947791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*